
Beritaz-P 4.5gm Injection
Marketer
Kritikos Care
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Beritaz-P 4.5gm Injection
Combiflox 4.5g Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on illness severity, adhering to their prescribed regimen is crucial. Potential side effects include nausea, vomiting, diarrhea, and skin rashes, alongside injection site reactions such as pain, swelling, or redness. Persistent or worsening symptoms require immediate medical consultation. Prior to use, disclose any antibiotic allergies, kidney, or liver conditions to your doctor; dosage adjustments or alternative medications may be necessary. Generally safe during pregnancy and lactation under medical guidance.
Primary Ingredients of Beritaz-P 4.5gm Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Beritaz-P 4.5gm Injection
Infections caused by bacteria
Major Benefits of Beritaz-P 4.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Beritaz-P 4.5gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Beritaz-P 4.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Beritaz-P 4.5gm Injection works:
Beritaz-P 4.5gm Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum complements this by counteracting bacterial resistance mechanisms, thus bolstering Piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Beritaz-P 4.5gm Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation Beritaz-P 4.5gm is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; however, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Beritaz-P 4.5gm is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Beritaz-P 4.5gm Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Beritaz-P 4.5gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Beritaz-P 4.5gm Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Beritaz-P 4.5gm Injection :
Should you forget a scheduled Beritaz-P 4.5gm Injection, seek medical advice.
Facts to Know About Beritaz-P 4.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
